查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2134023

類器官及球狀體市場：依產品類型、應用、最終用戶、技術、國家及地區分類－全球產業分析、市場規模、市場佔有率及2026-2033年預測

Organoids And Spheroids Market, By Product Type, By Application, By End User, By Technology, By Country, and By Region -Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 364 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，類器官和球狀體市場價值將達到 23.061 億美元，並將在 2026 年至 2033 年期間以 22.8% 的複合年成長率成長。

類器官和球狀體市場正圍繞著兩類3D細胞模型蓬勃發展：自組織類器官和類組織類器官，以及旨在推進疾病建模、藥物篩檢、毒性評估和轉化科學研究的多細胞球狀體。與傳統的2D培養相比，這些模型在細胞間相互作用、生物變異性和組織結構方面能更真實地再現組織，因此需要新的基質、培養系統、成像技術、檢測方法和自動化技術。儘管該領域仍以研究機構主導，但越來越多的生物技術和製藥公司正在臨床前藥物發現方案中利用這些模型。監管審查似乎也影響市場動態，FDA建議從2025年4月起在IND申報中使用包括類器官在內的「新方法」。

類器官和球狀體市場－市場動態

監管方向轉向與人類高度相關的「新調查方法」。

一項重大進展是類器官技術從基礎研究的生產工具轉變為近期獲準的臨床前開發證據生成技術。美國食品藥物管理局（FDA）2025年4月發布的藍圖建議在新藥臨床試驗申請（IND）中使用「新方法」獲得的數據，並強調基於類器官的毒性測試是應推廣的人體毒性測試方法之一。這導致製藥和生物技術客戶的採購要求發生了變化。如今，模型不僅必須具備生物有效性，還必須具備可重複性、表徵性、檢測相容性和監管效率。這種轉變促使供應商專注於建立具備標準化、培養、分析和篩檢能力的類器官技術，而不僅僅是銷售單一模型。

類器官和球狀體市場－市場細分分析：

全球類器官和球狀體市場按產品類型、應用、最終用戶、技術和地區進行細分。

從產品類型來看，產品分類表明，在生物複雜性和實驗可控性方面存在兩個不同的層次。球狀體作為較簡單的多細胞結構，在均一性和效率要求較高的篩檢、成像和檢測過程中具有吸引力。而類器官則需要更先進的培養和表徵技術，因為它們旨在實現更高水準的組織結構和功能。在致力於將3D模型整合到統一篩檢流程的實驗室中，這些工作方法上的差異正變得日益明顯。多倫多大學於2025年發布的一項方案展示了利用自動化技術在96孔盤和384孔板中使用SPOT類器官的方法，顯示類器官的製造流程正在不斷發展以適應自動化流程。

由於同一3D模型可能適用於藥物發現、轉換或臨床用途，因此最終使用者的需求可能存在顯著差異。學術和研究機構優先考慮實驗和模型開發的柔軟性，而生物製藥公司則更注重檢測的可重複性、流程通量和資料收集品質。臨床和診斷檢查室提出了新的要求：患者來源的模型必須將實驗室觀察與臨床相關的治療措施和檢驗的方案聯繫起來。 AACR-2025會議上提出的證據支持了這項轉變。根據PASS-01項目，來自183名患者的186份切片檢查樣本被用於建構患者來源的類器官，這些類器官隨後被用於對120多種藥物進行高通量篩檢。因此，最終用戶正在創造新的產品用途，從基於研究的應用到更實際的轉換應用。

類器官和球狀體市場—區域洞察

北美的重要性日益凸顯，這與生物醫學發展、監管現代化和商業化的融合密不可分。美國的情況較為特殊，聯邦政府正採取措施將與人類相關的技術融入生物醫學實踐。 2025年9月，美國國立衛生研究院（NIH）啟動了“標準化類器官建模中心”，旨在確保基於人工智慧、機器人技術和人類細胞的類器官調查方法的可重複性。該中心初期將聚焦在四個器官系統：肝臟、肺臟、心臟和腸道。此舉旨在解決行業面臨的主要挑戰之一：不同實驗室間結果的差異，並將模型開發與法規核准聯繫起來。結合藥物研發和臨床項目，這項基礎設施正在徹底改變該地區類器官在臨床前應用中的用途。

歐洲的一大優勢在於其已建立的廣泛的研究、臨床和產業生態系統，尤其是在荷蘭、德國和瑞士。歐洲並未將類器官的建構視為一個獨立的學術領域，而是建構了一個協作基礎設施，將類器官模型開發商、製藥公司、合約研究組織（CRO）和監管機構聚集在一起。根據荷蘭健康組織（Health~Holland）2025年2月發布的報告顯示，荷蘭和瑞士是類器官和晶片器官技術的領先國家，並在同月推出了舉措。這個生態系統擁有獨特的商業性和生產能力以及轉化研究網路的支持，其中包括烏得勒支的類器官專業知識。因此，歐盟市場是由其生態系統各組成部分的整合所塑造的，研究機構、技術開發人員和製藥公司透過共用的檢驗和臨床前應用框架進行了越來越多的合作。

目錄

第1章：類器官和球狀體市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 類器官與球狀體的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：類器官和球狀體的工業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：類器官與球狀體市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：類器官和球狀體的市場趨勢

  • 類器官和球狀體市場佔有率分析，2025 年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 類器官與球狀體市場：依產品類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按產品類型
    • 球體
    • 類器官

第8章 類器官與球狀體市場：依應用分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 再生醫學
    • 發育生物學
    • 疾病病理學研究
    • 個人化醫療
    • 藥物毒性和療效測試
    • 其他

第9章 類器官與球狀體市場：依最終使用者分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 學術研究機構
    • 生物技術和製藥業
    • 醫院和診斷中心

第10章 類器官與球狀體市場：依技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 微流體
    • 生物列印
    • 3D細胞培養
    • 利用支架進行培養
    • 其他

第11章 類器官與球狀體市場：依地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第12章：主要供應商分析：類器官和球狀體產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • 3D Biomatrix
    • Cellesce Ltd.
    • 3D Biotek LLC
    • Corning Incorporated
    • Greiner Bio-One
    • Hubrecht Organoid Technology（HUB）
    • AMS Biotechnology（Europe）Limited
    • InSphero
    • Lonza
    • STEMCELL Technologies Inc.
    • Merck KGaA
    • Prellis Biologics
    • Thermo Fisher Scientific, Inc.
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7469

Organoids And Spheroids Market size was valued at US$ 2,306.1 Million in 2025, expanding at a CAGR of 22.8% from 2026 to 2033.

A market for organoids and spheroids is emerging around two categories of 3D cell models: intrinsically self-assembling organoids and tissue-like organoids, as well as multi-cellular spheroids for disease modeling, drug screening, determining toxicity, and furthering translational science research, respectively. These models more closely mimic tissues with cell-cell interaction, biological variability, and tissue structure when compared to traditional 2D cultures, and this demands new matrices, culture systems, imaging techniques, assays, automation technologies, etc. The domain continues to be dominated by research labs, while more biotechnology and pharmaceutical companies now use these models in their drug development protocols in the preclinical phase. Regulatory scrutiny also appears to be influencing market dynamics, with the FDA encouraging the use of 'New Approach Methods,' including organoids, within IND applications from April 2025.

Organoids And Spheroids Market- Market Dynamics

Regulatory Shift Toward Human-Relevant New Approach Methodologies

An important development is the shift of organoids from production tools in basic research to a recently approved technology for generating evidence in preclinical development. The roadmap prepared by the FDA in April 2025 encouraged the use of data obtained with New Approach Methodologies in IND applications and mentioned organoid toxicity testing as a tool of human-based methods to be promoted. This leads to a change in purchasing requirements for pharmaceutical and biotechnology customers. It is no longer enough for a model to have biological relevance; it should also possess reproducibility, characterization, compatibility of assays, and regulatory efficiency. This change causes suppliers to work on creating organoid technology with its standardization, cultivation, analytical, and screening capabilities rather than selling separate models.

Organoids And Spheroids Market- Segmentation Analysis:

The Global Organoids And Spheroids Market is segmented on the basis of Product Type, Application, End User, Technology, and Region.

By product type, the categorization of products by type indicates that there are two different levels of biological intricacy and control over the experiments. Spheroids are simpler multicellular arrangements, making them attractive for screening, imaging, and assay processes where uniformity and efficiency are essential. On the other hand, organoids require more sophisticated culture and characterization techniques since they attempt to achieve higher levels of tissue organization and functionality. Such differences in the method of work become increasingly evident in laboratories trying to implement three-dimensional models into uniform screening processes. The 2025 University of Toronto protocol illustrates the use of SPOT organoids in the 96- and 384-well formats with the help of automation technology and shows that organoid manufacturing processes are changing to correspond to automated processes.

By end-user, requirements may differ significantly, as the same 3D model may be applied for discovery, translational, or clinical goals. Academic and research institutions value the flexibility of experimentation and model development, while biopharmaceutical companies focus widely on the reproducibility of assays, the throughput of processes, and the quality of data collected. Clinics and diagnostic labs have new requirements; that is, patient-derived models must link lab findings with clinically relevant treatment actions and verified protocols. Evidence presented at the AACR-2025 confirms this change: the PASS-01 project revealed that there were 186 biopsies from 183 patients sent for the production of patient-derived organoids, and these needs were followed by the high-output screening of more than 120 drugs. Thus, the end user is creating new types of consumption from research-based to more applicative and translational use of their products.

Organoids And Spheroids Market- Geographical Insights

The significance of North America is increasingly linked with the convergence of biomedical development, regulatory modernization, and commercialization. The United States stands as a uniquely specific case, as its federal administration takes steps to integrate human-relevant techniques into biomedical practices. In September 2025, the NIH started the implementation of the Standardized Organoid Modeling Center with the objective of ensuring reproducible organoid methodologies based on artificial intelligence, robotics, and human cells, initially covering four organ systems: the liver, lung, heart, and intestine. This initiative tackles one of the main challenges of the industry: variability of results across labs, and links model development to regulatory acceptance. Together with drug development and clinical programs, such infrastructure turns the region into one revolutionizing the use of organoids for preclinical applications.

Europe's major advantage arises from its wide-reaching research, clinical, and industrial ecosystem, especially in the Netherlands, Germany, and Switzerland. Instead of treating organoid production as a separate academic discipline, Europe has constructed a collaborative infrastructure that brings together developers of organoid models, pharma, CROs, and regulators. According to Health~Holland in February 2025, the Netherlands and Switzerland have become leading countries for organoid and organ-on-chip technologies, and that month they launched an initiative aimed at furthering cross-boundary collaboration on preclinical testing. The above ecosystem relies on the presence of special commercial and productive capacities and translational research networks, including organoid expertise in Utrecht. Thus, the EU's market is shaped by the integration of ecosystem components: research institutes, technical developers, and drug manufacturers are increasingly being integrated through shared frameworks for validation and preclinical use.

Organoids And Spheroids Market- Competitive Landscape:

The competition is firming based on the capacity to create intricate 3D biology that is reproducible, scalable, and useful in approved drug development processes. Major life science players like Merck and Corning compete based on their complementary abilities in culturing, media production, matrices, plates, and organoid knowledge. At the same time, niche technology providers like InSphero distinguish themselves through novel 3D assay technology and different model technologies. The competitive landscape is becoming more ecosystem-oriented with the creation of the Microphysiological Systems Industry Alliance in February 2025, involving nine founding companies, such as MIMETAS, InSphero, TissUse, and NETRI, which unite organoid and organ-on-chip developers for increased progressive application of human-relevant models. This indicates that competitive manufacturing technology is shifting away from specific organoid models towards the concept of full workflows, including culturing, automation, assays, and collecting translatable data.

Recent Developments:

In June 2025, Samsung Biologics announced the launch of Samsung Organoids, thereby bringing its capabilities to the industry of organoid-based drug screening and preclinical research services. The service is centered around dose-response screening based on the assessment of molecular candidates, rather than just producing organoids.

In April 2025, researchers from Keio University published their findings on hepatocyte organoid formation with preserved liver functions. The newly discovered method provides the opportunity to expand organoid production approximately 1,000,000 times within 3-4 weeks while ensuring the key functions of the liver are preserved.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ORGANOIDS AND SPHEROIDS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • 3D Biomatrix
  • Cellesce Ltd.
  • 3D Biotek LLC
  • Corning Incorporated
  • Greiner Bio-One
  • Hubrecht Organoid Technology (HUB)
  • AMS Biotechnology (Europe) Limited
  • InSphero
  • Lonza
  • STEMCELL Technologies Inc.
  • Merck KGaA
  • Prellis Biologics
  • Thermo Fisher Scientific, Inc.
  • Others

GLOBALORGANOIDS AND SPHEROIDS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033

  • Spheroids
  • Organoids

GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Regenerative Medicine
  • Developmental Biology
  • Disease Pathology Studies
  • Personalized Medicine
  • Drug Toxicity & Efficacy Testing

GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Academic & Research Institutes
  • Biotechnology and Pharmaceutical Industries
  • Hospitals and Diagnostic Centers

GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Microfluidics
  • Bioprinting
  • 3D Cell Culture
  • Scaffold-Based Culture
  • Others

GLOBAL ORGANOIDS AND SPHEROIDS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Organoids And Spheroids Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Organoids And Spheroids Market Snippet by Product Type
    • 2.1.2. Organoids And Spheroids Market Snippet by Application
    • 2.1.3. Organoids And Spheroids Market Snippet by End User
    • 2.1.4. Organoids And Spheroids Market Snippet by Technology
    • 2.1.5. Organoids And Spheroids Market Snippet by Country
    • 2.1.6. Organoids And Spheroids Market Snippet by Region
  • 2.2. Competitive Insights

3. Organoids And Spheroids Key Market Trends

  • 3.1. Organoids And Spheroids Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Organoids And Spheroids Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Organoids And Spheroids Market Opportunities
  • 3.4. Organoids And Spheroids Market Future Trends

4. Organoids And Spheroids Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Organoids And Spheroids Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Organoids And Spheroids Market Landscape

  • 6.1. Organoids And Spheroids Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Organoids And Spheroids Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
    • 7.1.2. Spheroids
    • 7.1.3. Organoids

8. Organoids And Spheroids Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 8.1.2. Regenerative Medicine
    • 8.1.3. Developmental Biology
    • 8.1.4. Disease Pathology Studies
    • 8.1.5. Personalized Medicine
    • 8.1.6. Drug Toxicity & Efficacy Testing
    • 8.1.7. Others

9. Organoids And Spheroids Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 9.1.2. Academic & Research Institutes
    • 9.1.3. Biotechnology and Pharmaceutical Industries
    • 9.1.4. Hospitals and Diagnostic Centers

10. Organoids And Spheroids Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 10.1.2. Microfluidics
    • 10.1.3. Bioprinting
    • 10.1.4. 3D Cell Culture
    • 10.1.5. Scaffold-Based Culture
    • 10.1.6. Others

11. Organoids And Spheroids Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Organoids And Spheroids Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Organoids And Spheroids Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.17. Denmark
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.3.18. Rest of Europe
      • 11.3.18.1. Overview
      • 11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.3.18.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.18.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.3.18.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Organoids And Spheroids Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.16. Taiwan
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.17. Vietnam
      • 11.4.17.1. Overview
      • 11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.17.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.17.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.17.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.17.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.4.18. Rest of APAC
      • 11.4.18.1. Overview
      • 11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.18.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.4.18.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.18.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.4.18.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Organoids And Spheroids Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Organoids And Spheroids Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.14. Iran
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.15. Qatar
      • 11.6.15.1. Overview
      • 11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.15.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.15.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.15.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.15.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 11.6.16. Rest of MEA
      • 11.6.16.1. Overview
      • 11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.16.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
      • 11.6.16.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.16.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
      • 11.6.16.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Organoids And Spheroids Industry

  • 12.1. Competitive Benchmarking
    • 12.1.1. Competitive Dashboard
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. 3D Biomatrix
    • 12.2.2. Cellesce Ltd.
    • 12.2.3. 3D Biotek LLC
    • 12.2.4. Corning Incorporated
    • 12.2.5. Greiner Bio-One
    • 12.2.6. Hubrecht Organoid Technology (HUB)
    • 12.2.7. AMS Biotechnology (Europe) Limited
    • 12.2.8. InSphero
    • 12.2.9. Lonza
    • 12.2.10. STEMCELL Technologies Inc.
    • 12.2.11. Merck KGaA
    • 12.2.12. Prellis Biologics
    • 12.2.13. Thermo Fisher Scientific, Inc.
    • 12.2.14. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us